Equine CYFRA21-1 antibody and antigen (recombinant protein)
Diagnostic anti-Equine CYFRA21-1 antibodies pairs and antigen for animal health (animal Equine/Horse bronchopulmonary dysplasia) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-EQU-CYFRA21-1-Ag01 | Recombinant Equine CYFRA21-1 protein | 3090 |
GMP-EQU-CYFRA21-1-Ab01 | Anti-Equine CYFRA21-1 mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-CYFRA21-1-Ab02 | Anti-Equine CYFRA21-1 mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-CYFRA21-1-Ab03 | Anti-Equine CYFRA21-1 human monoclonal antibody (mAb) | 1953 |
GMP-EQU-CYFRA21-1-Ab04 | Anti-Equine CYFRA21-1 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-EQU-CYFRA21-1-Ag01 |
Product Name | Recombinant Equine CYFRA21-1 protein |
Target/Biomarker | Equine soluble fragment of cytokeratin-19 (CYFRA21-1) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine soluble fragment of cytokeratin-19 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CYFRA21-1 level test of animal Equine/Horse with bronchopulmonary dysplasia. |
Tag | His |
Products description | Recombinant Equine CYFRA21-1 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-CYFRA21-1-Ab01, GMP-EQU-CYFRA21-1-Ab02 |
Product Name | Anti-Equine CYFRA21-1 mouse monoclonal antibody (mAb) |
Target/Biomarker | Equine soluble fragment of cytokeratin-19 (CYFRA21-1) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Equine soluble fragment of cytokeratin-19 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-CYFRA21-1 antibodies in CYFRA21-1 level test of animal Equine/Horse with bronchopulmonary dysplasia. |
Tag | mFc |
Products description | Anti-Equine CYFRA21-1 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-CYFRA21-1 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-CYFRA21-1-Ab03, GMP-EQU-CYFRA21-1-Ab04 |
Product Name | Anti-Equine CYFRA21-1 human monoclonal antibody (mAb) |
Target/Biomarker | Equine soluble fragment of cytokeratin-19 (CYFRA21-1) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Equine soluble fragment of cytokeratin-19 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-CYFRA21-1 antibodies in CYFRA21-1 level test of animal Equine/Horse with bronchopulmonary dysplasia. |
Tag | hFc |
Products description | Anti-Equine CYFRA21-1 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-CYFRA21-1 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
CYFRA21-1, also known as Cytokeratin 19 Fragment 21-1 (CYFRA 21-1), is a biomarker of significant importance within the realm of horses (equines). This biomarker originates from cytokeratin 19, a structural protein that plays a pivotal role in maintaining the integrity of the cytoskeleton of epithelial cells. Epithelial cells are a fundamental component of various equine tissues, including the respiratory system. When these cells undergo pathological changes, such as injury or malignant transformation, CYFRA21-1 fragments can be released into the bloodstream, making it a valuable indicator of the health of the respiratory and epithelial systems in equines. At the molecular level, CYFRA21-1 consists of specific fragments of cytokeratin 19, with the 21-1 fragment being a notable component. These soluble protein fragments can be detected through blood tests. In healthy horses, CYFRA21-1 levels are typically low. However, when there is damage or malignancy in epithelial tissues, particularly in the lungs, the levels of CYFRA21-1 can significantly increase. This phenomenon makes CYFRA21-1 a crucial biomarker for assessing the health of the respiratory and epithelial systems in equines.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.